Delivery Order SPE2DX22D0010-SPE2D825FJF32
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a $8,025.61 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Metadate CD Caps 20mg, a central nervous system stimulant medication commonly prescribed for attention deficit hyperactivity disorder. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with the Defense Logistics Agency and is scheduled for completion by...
- The U.S. Defense Medical Supply Chain has awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 30mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This non-set-aside competitive award, issued on September 4, 2025, carries a ceiling value of $3,447.55 and is scheduled for completion by September 5, 2025. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Metadate CD Caps 30mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This firm fixed price delivery order, valued at $8,397.85 with a completion deadline of August 26, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Metadate CD Caps 20mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $16,551.16, represents a non-competitive set-aside award and is scheduled for completion by August 19, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Metadate CD Caps 20mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,006.19 and an ultimate completion date of August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $5,070.29 delivery order award from the Defense Logistics Agency's Medical Supply Chain for Metadate CD Caps 10mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of September 3,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Metadate CD Caps 20mg, a prescription medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $5,961.67, represents a non-set-aside competitive award and is scheduled for completion by July 31, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Metadate CD 30mg tablets, valued at $9,277.04. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,749.22 to AmerisourceBergen Drug Corp for Metadate CD Caps 20mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This non-competitive, firm fixed-price delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract...
- The U.S. Department of Defense's Medical Supply Chain awarded a $2,278.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 20mg on July 21, 2025, with completion targeted for July 22, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, which carries a $999,999,999.00 ceiling and extends through December 2026. The...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJF32Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a $5,591.54 delivery order for Metadate CD Caps 30mg, a prescription stimulant medication used in the treatment of attention deficit hyperactivity disorder. The contract was competitively awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor for medical procurement supporting defense and veteran healthcare systems. The contract employs firm fixed-price pricing with no set-aside designation, reflecting the contractor's demonstrated capability to compete effectively in open procurements. This award continues AmerisourceBergen's extensive portfolio of federal pharmaceutical deliveries spanning multiple therapeutic domains, including specialty medications, generic drugs, and medical supplies across the Department of Defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/9/25 |